Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET
Company Participants
Michael Grabow - Executive Vice President of Chief Business Officer
Thomas Riga - President and Chief Executive Officer
Francois J. Lebel - Executive Vice President and Chief Medical Officer
Nora Brennan - Executive Vice President and Chief Financial Officer
Erin Miller - Senior Vice President Sales and Marketing
Conference Call Participants
Ed White - H.C. Wainwright
Prakhar Agarwal - Cantor Fitzgerald
Operator
Good day and thank you for standing by. Welcome to the Spectrum Pharmaceuticals Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Michael Grabow, Executive Vice President of Chief Business Officer. Please go ahead.
Michael Grabow
Thank you, operator. Welcome to Spectrum Pharmaceuticals third quarter 2022 earnings call. With me on today’s call are Spectrum’s President and Chief Executive Officer, Tom Riga; Executive Vice President and Chief Medical Officer, Dr. Francois Lebel; Executive Vice President and Chief Financial Officer, Nora Brennan; and Senior Vice President, Sales and Marketing, Erin Miller.
Earlier today, Spectrum issued a press release detailing its financial results for the three months ended September 30, 2022. This press release and webcast of this call can be accessed through the Investor Relations of the Spectrum website at sppirx.com.
Before we get started, I would like to reference the notice regarding forward-looking statements included in today’s press release. This notice emphasizes the major uncertainties and risks inherent in the forward-looking statements we will make this afternoon. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. A telephone replay will be available shortly after completion of this call. The archived webcast will be available for one year on our website at sppirx.com. For the benefit of those who maybe listening to the replay or archived webcast, this call is held on November 10, 2022. Since then, Spectrum may have made announcements related to the topics discussed, so please refer to the company’s most recent press releases and SEC filings.